You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firm signed a deal with Zotal to be exclusive Israeli distributor of the test, which measures proteins in patient blood to detect diabetic kidney disease.
The European Commission recently awarded the company a two-year, €2.6 million Horizon 2020 grant to achieve its ambitions.
The product, which received the CE mark earlier this year, uses digital imaging and AI to automate peripheral blood smear analysis.
Under a licensing deal, Omixon will sell the AzureSeq-200 RT-PCR kit under its brand in Europe, the Middle East, and Africa.
The firm's single-step pooling approach, which can be used in areas with high disease prevalence, allows labs to multiply their testing capacity.
The companies will form a joint venture for Todos' cancer tests with Care GB owning 67 percent and Todos owning 33 percent of the new venture.
Under the agreement, DiaSorin will make the test, which distinguishes between viral and bacterial infections, available on its Liaison analyzer platform.
Todos also announced a $23.8 million sales agreement this week with an unnamed Wisconsin laboratory covering testing equipment and supplies.
Under the agreement, Unilabs will help test airline passengers flying into UAE to determine if they are infected with the virus.
The company has also seen uptake of HemoScreen in Europe and Australia since PixCell began selling the portable hematology analyzer in those markets.